Amneal reports third quarter 2021 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced its results today for the third quarter ended september 30, 2021. “our solid third quarter results further validate our strategy for growth and value creation, focused on operational excellence and a robust innovation engine to strengthen and diversify amneal,” said chirag and chintu patel, co-chief executive officers. “we are pleased to be raising our adjusted ebitda guidance for
AMRX Ratings Summary
AMRX Quant Ranking